DeFiance Daily – Apimeds Pharmaceuticals and MindWave Innovations have signed a merger agreement that unites late-stage biotech development with AI-driven Bitcoin treasury infrastructure. Supported by a PIPE of up to $100 million, the combined company pairs non-opioid therapeutics with institutional digital-asset yield generation.
Apimeds and MindWave Merge to Fuse Biotech and AI-Powered Digital Treasury
Published December 4, 2025